Table 2.
Univariate and multivariate logistic regression analysis
| Variables | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| OR (95% CI) | p value | OR (95% CI) | p value | |
| Male, n (%) | 1.55 (0.90∼2.69) | 0.116 | | |
| Hypertension, n (%) | 1.53 (0.86∼2.71) | 0.151 | | |
| Diabetes mellitus, n (%) | 1.37 (0.76∼2.47) | 0.295 | | |
| Smoking, n (%) | 0.85 (0.47∼1.55) | 0.604 | | |
| Killip >1, n (%) | 1.72 (0.87∼3.40) | 0.118 | | |
| LAD, n (%) | 2.71 (1.51∼4.87) | <0.001 | 3.00 (1.61∼5.59) | <0.001 |
| LCX, n (%) | 0.59 (0.23∼1.53) | 0.279 | | |
| RCA, n (%) | 0.53 (0.28∼1.02) | 0.056 | | |
| ACEI/ARB, n (%) | 1.01 (0.58∼1.75) | 0.972 | | |
| Beta-blockers, n (%) | 0.62 (0.31∼1.25) | 0.183 | | |
| Age, years | 1.01 (0.99∼1.04) | 0.312 | | |
| Heart rate, bpm | 1.00 (0.98∼1.02) | 0.907 | | |
| SBP, mmHg | 0.99 (0.98∼1.01) | 0.348 | | |
| DBP, mmHg | 1.00 (0.98∼1.02) | 0.830 | | |
| LVEF, % | 0.98 (0.96∼1.00) | 0.045 | 0.98 (0.95∼1.00) | 0.077 |
| Left atrial diameter, mm | 1.03 (1.00∼1.07) | 0.162 | | |
| CRP, mg/L | 1.01 (1.00∼1.01) | 0.015 | 1.01 (1.00∼1.01) | 0.007 |
| hs-TnT, pg/mL | 1.75 (1.01∼3.05) | 0.049 | 1.76 (0.96∼3.24) | 0.067 |
| sST2, ng/mL | 1.01 (1.01∼1.02) | <0.001 | 1.02 (1.01∼1.02) | <0.001 |
| BMI, kg/m2 | 0.95 (0.85∼1.06) | 0.330 | | |
| NT-proBNP, pg/mL | 2.04 (1.21∼3.42) | 0.007 | 2.21 (1.25∼3.91) | 0.006 |
| eGFR, mL/min/1.73 m2 | 1.00 (0.99∼1.02) | 0.556 | | |
| FBG, mmol/L | 1.03 (0.94∼1.12) | 0.529 | | |
| TC, mmol/L | 1.13 (0.86∼1.48) | 0.375 | | |
| TG, mmol/L | 1.16 (0.96∼1.41) | 0.126 | | |
| HDL, mmol/L | 0.64 (0.19∼2.16) | 0.475 | | |
| LDL, mmol/L | 1.15 (0.85∼1.56) | 0.366 | | |
NOAF, new-onset atrial fibrillation; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; hs-TnT, high-sensitivity troponin T; NT-proBNP, N-terminal pro-B-type natriuretic peptide; CRP, C-reactive protein; LDL, low-density leptin cholesterol; HDL, high-density leptin cholesterol; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; LVEF, left ventricular ejection fraction; LAD, left anterior descending; LCX, left circumflex artery; RCA, right coronary artery; LM, left main coronary artery; sST2, soluble suppression of tumorigenicity 2.